Maso Capital Partners’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Maso Capital Partners’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-150,000	Closed	-$3.2M	–	39
2024 Q1	$3.2M	Buy	+150,000	New	+$1.79M	2.36%	8

Maso Capital Partners's FUSN Position: Q2 2024 in Review

Maso Capital Partners sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 150,000 shares — an estimated $3.2M sold.

Maso Capital Partners first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $3.2M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Maso Capital Partners reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Maso Capital Partners sold 150,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $3.2M.
Maso Capital Partners first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Maso Capital Partners's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.2M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Maso Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.